• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性和继发性肝癌的切除与手术消融综述

A Review of Resection and Surgical Ablation for Primary and Secondary Liver Cancers.

作者信息

White McKenzie J, Jensen Eric H, Brauer David G

机构信息

Department of Surgery, University of Minnesota, Minneapolis, Minnesota.

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.

出版信息

Semin Intervent Radiol. 2024 Jan 24;40(6):536-543. doi: 10.1055/s-0043-1777747. eCollection 2023 Dec.

DOI:10.1055/s-0043-1777747
PMID:38274223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10807965/
Abstract

The surgical management of primary and secondary liver tumors is constantly evolving. Patient selection, particularly with regard to determining resectability, is vital to the success of programs directed toward invasive treatments of liver tumors. Particular attention should be paid toward determining whether patients are best served with surgical resection or ablative therapies. A multidisciplinary approach is necessary to provide optimal care to patients with liver malignancy.

摘要

原发性和继发性肝肿瘤的外科治疗一直在不断发展。患者的选择,尤其是在确定可切除性方面,对于针对肝肿瘤进行侵入性治疗的方案的成功至关重要。应特别注意确定患者最适合接受手术切除还是消融治疗。采用多学科方法对于为肝恶性肿瘤患者提供最佳护理是必要的。

相似文献

1
A Review of Resection and Surgical Ablation for Primary and Secondary Liver Cancers.原发性和继发性肝癌的切除与手术消融综述
Semin Intervent Radiol. 2024 Jan 24;40(6):536-543. doi: 10.1055/s-0043-1777747. eCollection 2023 Dec.
2
The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.消融疗法治疗肝转移瘤的临床疗效和成本效果:系统评价和经济评估。
Health Technol Assess. 2014 Jan;18(7):vii-viii, 1-283. doi: 10.3310/hta18070.
3
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
4
Locoregional Therapies for Colorectal Cancer Liver Metastases: Options Beyond Resection.结直肠癌肝转移的局部区域治疗:除切除术之外的选择。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:133-146. doi: 10.1200/EDBK_320519.
5
Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.肝切除术与热消融治疗结直肠癌肝转移高危患者的比较:LAVA 国际 RCT。
Health Technol Assess. 2020 Apr;24(21):1-38. doi: 10.3310/hta24210.
6
Surgical treatment of liver metastases in patients with neuroendocrine tumors.神经内分泌肿瘤患者肝转移的外科治疗。
Ann Transl Med. 2013 Apr;1(1):6. doi: 10.3978/j.issn.2305-5839.2013.01.08.
7
Hepatocellular carcinoma in the modern era: transplantation, ablation, open surgery or minimally invasive surgery? -A multidisciplinary personalized decision.现代肝细胞癌:肝移植、消融、开放手术还是微创手术?——多学科个性化决策
Chin Clin Oncol. 2013 Dec;2(4):35. doi: 10.3978/j.issn.2304-3865.2013.07.03.
8
What's New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update.经皮消融治疗肝细胞癌和结直肠癌肝转移的新进展:2020 年更新。
Curr Oncol Rep. 2020 Jul 28;22(10):105. doi: 10.1007/s11912-020-00967-y.
9
SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.SAGES/AHPBA关于使用微波和射频肝消融术治疗直径小于5厘米的肝细胞癌或结直肠癌肝转移瘤的手术治疗指南。
Surg Endosc. 2023 Dec;37(12):8991-9000. doi: 10.1007/s00464-023-10468-1. Epub 2023 Nov 13.
10
Hepatic surgery for metastases from neuroendocrine tumors.神经内分泌肿瘤肝转移的肝手术治疗
Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. doi: 10.1016/s1055-3207(02)00076-5.

本文引用的文献

1
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.度伐利尤单抗联合吉西他滨和顺铂治疗晚期胆道癌。
NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1.
2
Feasibility of laparoscopic microwave ablation of caudate tumors: a case series.腹腔镜微波消融治疗尾状叶肿瘤的可行性:病例系列研究
J Surg Case Rep. 2023 Aug 23;2023(8):rjad478. doi: 10.1093/jscr/rjad478. eCollection 2023 Aug.
3
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy.E-AHPBA-ESSO-ESSR 因斯布鲁克共识指南:肝切除术术前肝脏功能评估。
Br J Surg. 2023 Sep 6;110(10):1331-1347. doi: 10.1093/bjs/znad233.
4
A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC).微波消融与切除术治疗可切除结直肠癌肝转移的生存前瞻性多中心研究(MAVERRIC)。
Eur J Cancer. 2023 Jul;187:65-76. doi: 10.1016/j.ejca.2023.03.038. Epub 2023 Apr 5.
5
Predictive Factors for Local Recurrence after Intraoperative Microwave Ablation for Colorectal Liver Metastases.结直肠癌肝转移术中微波消融术后局部复发的预测因素
Cancers (Basel). 2022 Dec 25;15(1):122. doi: 10.3390/cancers15010122.
6
Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinoma.肝门部胆管癌胆汁引流随机试验的长期随访
HPB (Oxford). 2023 Feb;25(2):210-217. doi: 10.1016/j.hpb.2022.10.009. Epub 2022 Oct 21.
7
Association Between Frailty and Time Alive and At Home After Cancer Surgery Among Older Adults: A Population-Based Analysis.老年癌症患者术后虚弱与存活时间及居家时间的关联:基于人群的分析
J Natl Compr Canc Netw. 2022 Nov;20(11):1223-1232.e9. doi: 10.6004/jnccn.2022.7052.
8
Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022.肝脏手术围手术期护理指南:加速康复外科(ERAS)协会 2022 年推荐意见。
World J Surg. 2023 Jan;47(1):11-34. doi: 10.1007/s00268-022-06732-5. Epub 2022 Oct 30.
9
Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver-A Single Centre Study.非肝硬化肝脏肝细胞癌切除术后的结局——一项单中心研究
J Clin Med. 2022 Sep 30;11(19):5802. doi: 10.3390/jcm11195802.
10
Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).热消融治疗结直肠癌肝转移的疗效改善:来自前瞻性阿姆斯特丹 CORE 登记研究(AmCORE)的 10 年分析。
Cardiovasc Intervent Radiol. 2022 Aug;45(8):1074-1089. doi: 10.1007/s00270-022-03152-9. Epub 2022 May 18.